Observational studyAnnals of neurology2022

Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.

Ilya Kister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.